ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.508,00
-0,50%
S&P 500
5.631,22
0,00%
Dow Jones
40.211,72
0,00%
Euro vs US Dollar
1,08845
-0,14%
Bitcoin
63.799,71
-1,62%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) News

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPRX
DatumZeitQuelleÜberschriftSymbolFirma
05/06/201914h50GlobeNewswire Inc.OptimizeRx Announces Pricing of Public Offering of Common StockNASDAQ:OPRXOptimizeRx Corporation
04/06/201922h12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPRXOptimizeRx Corporation
04/06/201922h01GlobeNewswire Inc.OptimizeRx Announces Proposed Public Offering of Common StockNASDAQ:OPRXOptimizeRx Corporation
31/05/201918h52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
31/05/201916h30GlobeNewswire Inc.OptimizeRx to Participate at Investor Conferences in JuneNASDAQ:OPRXOptimizeRx Corporation
22/05/201923h04Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OPRXOptimizeRx Corporation
17/05/201922h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
13/05/201922h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
13/05/201914h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
10/05/201922h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
09/05/201914h46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
08/05/201922h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPRXOptimizeRx Corporation
08/05/201922h01GlobeNewswire Inc.OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $...NASDAQ:OPRXOptimizeRx Corporation
03/05/201923h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
03/05/201923h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
03/05/201923h08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPRXOptimizeRx Corporation
03/05/201923h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
30/04/201916h21PR Newswire (US)EVERSANA and OptimizeRx Partner to Deliver High Tech and High Touch Pharmaceutical ServicesNASDAQ:OPRXOptimizeRx Corporation
29/04/201915h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
29/04/201914h31GlobeNewswire Inc.OptimizeRx Strengthens Executive Leadership with Appointment of Chief Commercial OfficerNASDAQ:OPRXOptimizeRx Corporation
26/04/201922h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
26/04/201917h30GlobeNewswire Inc.OptimizeRx Sets First Quarter 2019 Conference Call for Wednesday, May 8, 2019 at 4:30 p.m. ETNASDAQ:OPRXOptimizeRx Corporation
23/04/201918h57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
23/04/201914h31GlobeNewswire Inc.OptimizeRx to Present at Investor Conferences in MayNASDAQ:OPRXOptimizeRx Corporation
08/04/201915h59Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
08/04/201914h31GlobeNewswire Inc.OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tech and Personnel AddsNASDAQ:OPRXOptimizeRx Corporation
29/03/201921h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
29/03/201921h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
29/03/201921h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
29/03/201921h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX

Kürzlich von Ihnen besucht

DBI
DAX
DAX
NYSE
KO
Coca Cola
CCOM
US30
US 30
AMEX
XLF
Financial Select Sector
TG
CBK
Commerzbank
NYSE
JPM
JP Morgan Chase
TG
DTE
Deutsche Telekom
USOTC
ADDYY
Adidas (QX)
DBI
SDXP
SDAX
NYSE
MCD
McDonalds
TG
BAS
BASF
TG
NOV
Novo Nordisk
NASDAQ
AAPL
Apple
TG
BAYN
Bayer
TG
432
Arbor Metals
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten